Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC

Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, USA
Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC ( Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, USA )
8 Oct 2026

Isa-VRd shows sustained benefit in transplant-ineligible newly diagnosed multiple myeloma

Prof Xavier Leleu - Poitiers University Hospital, Poitiers, France
Isa-VRd shows sustained benefit in transplant-ineligible newly diagnosed multiple myeloma ( Prof Xavier Leleu - Poitiers University Hospital, Poitiers, France )
7 Oct 2026

Using artificial intelligence to improve lung cancer screening and risk prediction

Dr Ricardo Santos - President, Instituto ProPulmão
Using artificial intelligence to improve lung cancer screening and risk prediction ( Dr Ricardo Santos - President, Instituto ProPulmão )
6 Oct 2026

Subcutaneous tarlatamab shows encouraging efficacy in previously treated extensive-stage SCLC

Dr Luis Paz-Ares - 12 de Octubre University Hospital, Madrid, Spain
Subcutaneous tarlatamab shows encouraging efficacy in previously treated extensive-stage SCLC ( Dr Luis Paz-Ares - 12 de Octubre University Hospital, Madrid, Spain )
6 Oct 2026

Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma

Dr Giulia Pasello - University of Padua, Padua, Italy
Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma ( Dr Giulia Pasello - University of Padua, Padua, Italy )
6 Oct 2026

Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours

Dr Stefano Avanzini - Giannina Gaslini Institute, Genoa, Italy
Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours ( Dr Stefano Avanzini - Giannina Gaslini Institute, Genoa, Italy )
1 Oct 2026

Functional dependence predicts poorer survival in adults aged 80 and over with NSCLC

Dr María Paula Uchima - Fundación Santa Fe de Bogotá, Bogotá, Colombia
Functional dependence predicts poorer survival in adults aged 80 and over with NSCLC ( Dr María Paula Uchima - Fundación Santa Fe de Bogotá, Bogotá, Colombia )
1 Oct 2026

Subcutaneous tarlatamab shows promising safety and activity in previously treated extensive-stage SCLC

Dr Pedro Rocha - Vall d'Hebron University Hospital, Barcelona, Spain
Subcutaneous tarlatamab shows promising safety and activity in previously treated extensive-stage SCLC ( Dr Pedro Rocha - Vall d'Hebron University Hospital, Barcelona, Spain )
1 Oct 2026

TELENEC reduces referral delays for childhood cancer care in Paraguay

Dr Diego Figueredo - Universidad Nacional de Asunción, San Lorenzo, Paraguay
TELENEC reduces referral delays for childhood cancer care in Paraguay ( Dr Diego Figueredo - Universidad Nacional de Asunción, San Lorenzo, Paraguay )
29 Sep 2026

Drone delivery could improve access to childhood cancer medicines in Ghana

Dr Dhwani Babla - St. Jude Children’s Research Hospital, Memphis, USA
Drone delivery could improve access to childhood cancer medicines in Ghana ( Dr Dhwani Babla - St. Jude Children’s Research Hospital, Memphis, USA )
29 Sep 2026

Transcriptome-Wide Association Study identifies genetic factors linked to subsequent cancers in childhood cancer survivors

Dr Michael Betti - St. Jude Children's Research Hospital, Memphis, USA
Transcriptome-Wide Association Study identifies genetic factors linked to subsequent cancers in childhood cancer survivors ( Dr Michael Betti - St. Jude Children's Research Hospital, Memphis, USA )
29 Sep 2026

Adjuvant osimertinib delivers sustained long term survival benefit in EGFR mutated NSCLC

Dr Roy Herbst - Dartmouth Cancer Center, Lebanon, USA
Adjuvant osimertinib delivers sustained long term survival benefit in EGFR mutated NSCLC ( Dr Roy Herbst - Dartmouth Cancer Center, Lebanon, USA )
28 Sep 2026